fbpx

Happy Pride Month!

Fueling Discovery Gene By Gene.

What We Do

Deliver answers more effectively by using alternative, non-mammalian model organisms in early biological and biomedical research.

what-we-do

The InVivo Biosystems Technology provides the deep insights you need to make a go/no-go decision. Our data analysis and focused team of experts will also help you to understand the results and identify alternate routes and hypotheses you may not have seen previously.

Who We Serve

InVivo Biosystems provides essential analytical services enabling pharmaceutical, nutraceutical,  biotechnology companies and research institutions around the globe to accelerate their research and drug discovery efforts.

Solution-3

The InVivo Biosystems Technology provides the deep insights you need to make a go/no-go decision.  Our data analysis and focused team of experts will also help you to understand the results and identify alternate routes and hypotheses you may not have seen previously.

What would you like to do?

Modify

Modify

Genome-edited C. elegans or zebrafish built to your specification.

Available Services:
C. elegans Genome-Editing | Zebrafish Genome-Editing
Humanized Models | Co-CRISPR Screening Kit

prepare

Prepare

Start critical first steps in your experiment with worm-prep reagents & tools.

Featured Reagents:
NemaGel | C. elegans Lysis Kit
PCR Master Mix | Genotyping Reagent Bundle

measure

Measure

Visualize, measure C. elegans behavior and collect phenotypic output.

Featured Instruments:
Nema Imager | C. elegans Synchronizer
ScreenChip™ System | wMicroTracker

in-vivo

In-Vivo Analytical Services

Shorten your timeline using our turn-key services to test your hypothesis or prove your concept.

Available Services:
Lifespan & Healthspan Analysis | In Vivo Toxicity Testing
Custom In Vivo Testing

What's New

Sample Report

Sample data from Longevity Platform

Download our sample data report to see an example of the dataset you would receive if you partnered with us. Download Now.

Case Study

IVB-Case-Study_-STXBP1-Humanization-3-768x994

Case study highlighting how the InVivo Biosystems Technology was used to examine 3 variants of STXBP1 in order to better understand each variant’s status as pathogenic or benign and to outline a phenotype-based model of the variant landscape. Download Now.

Customer Story

Customer Story

Dr. Vollmer (Chief Scientific Officer at 4Life Research) shares his experience in working with InVivo Biosystems and how the Longevity Platform delivers the results he needs within his timeline and budget. Download Now.

Latest Posts

The Application of Hypersensitivity Assays to the Discovery of Therapeutics

Summary Using Humanization we can take advantage of the ancient biology between humans and other organisms to create stand-ins - patient avatars - for ...
Read More

Let’s Fail Faster: Why Scientific Failures Should be Accepted as Progress

Summary In the scientific community there is an emphasis on positive results: getting published, having a drug be approved, etc. However, crucial learning happens ...
Read More

Seventeen Minutes of Science: Understanding Disease Biology Through Machine Learning and Computer Models

Tune in weekly to our virtual series "Seventeen Minutes of Science" every Tuesday at 11am PST / 2pm ET where we go live on ...
Read More

Stay Informed & Up-to-date

The InVivo Biosystems Newsletter is delivered to your inbox bi-weekly, giving you all of the latest company updates, industry news, and more. Read our latest newsletter ».

READY TO GET STARTED?

Ready to connect with us to learn more about working with our company or our technology?

Scroll to Top